Encyclopedia

  • Paradoxical effects of oxytocin and vasopressin on basal prolactin secretion and the estrogen-induced prolatin surge
  • Add time:08/08/2019         Source:sciencedirect.com

    The roles of oxytocin (OT) and vasopressin (AVP) on both basal and estrogen-induced prolactin (PRL) secretion were examined. Adult female Sprague-Dawley rats that were ovariectomized for 3 weeks and received estrogen treatment for 1 week were used. Intravenous administration of hormones and serial blood sampling were accomplished through indwelling intraatrial catheters which were implanted two days before. Plasma PRL levels were measured by radioimmunoassay. Oxytocin at a dose of 20 μg/rat stimulated a moderate PRL release in the morning and lower doses (5 and 10 μg) were without effect. Vasopressin was most effective at a dose of 5 μg/rat in stimulating PRL release, while consecutive injections of higher doses (10 and 20 μg) were less effective. In contrast, TRH, ranging from 1 to 8 μg/rat, induced a dose-dependent increases in PRL secretion. Using the effective dosages determined from the morning studies, repeated injections of either OT, AVP or their specific antagonists MPOMeOVT ([1-(β-mercapto-β, β-cyclopentamethylene propanoic acid), 2-(0-methyl) tyrosine, 8-ornithine]-vasotocin) and d(CH2) 5Tyr (me) AVP ([1-(β-mercapto-β, β-cyclo-pentamethylene propionic acid), 2-(0-methyl) tyrosine, 8-arginine]-vasopressin), were given hourly between 1300 to 1800h and blood samples were obtained hourly from 1100 to 1900h. It was found that either OT or AVP significantly reduced the afternoon PRL surge, while their antagonists were not as effective. When OT or AVP were administered together with their specific antagonists, the inhibitory effects of either hormone on PRL surge were reserved. Thus it is concluded that both OT and AVP assume a non-specific stress-like effect on PRL release, in which basal secretion is stimulated and surge secretion is inhibited.

    We also recommend Trading Suppliers and Manufacturers of oxytocin, -1-(beta-mercapto-(beta,beta-cyclopentamethylene)propionic acid)-Phe(Me)(2)-Thr(4)-Orn(8)- (cas 110220-69-4). Pls Click Website Link as below: cas 110220-69-4 suppliers


    Prev:[2+2] cycloadditions of 2,2-bis(trifluoromethyl)ethylene-1,1-dicarbonitrile with enol ethers, 1,1-dimethylbutadiene, and allyltrimethylsilane
    Next: A comparison of the antibacterial and β-lactamase inhibiting properties of penam and (2,3)-β-methylenepenam derivatives)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View